These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7689178)

  • 41. Uptake of botulinum neurotoxin into cultured neurons.
    Keller JE; Cai F; Neale EA
    Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A.
    Yu YZ; Ma Y; Chen YX; Gong ZW; Wang S; Yu WY; Sun ZW
    Hum Vaccin; 2011 Oct; 7(10):1090-5. PubMed ID: 21941093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GHRH receptor-targeted botulinum neurotoxin selectively inhibits pulsatile GH secretion in male rats.
    Leggett J; Harper E; Waite E; Marks P; Martinez A; Lightman S
    Endocrinology; 2013 Sep; 154(9):3305-18. PubMed ID: 23825127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
    Wheeler A; Smith HS
    Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity.
    Ihara H; Kohda T; Morimoto F; Tsukamoto K; Karasawa T; Nakamura S; Mukamoto M; Kozaki S
    Biochim Biophys Acta; 2003 Jan; 1625(1):19-26. PubMed ID: 12527421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin.
    Rummel A; Mahrhold S; Bigalke H; Binz T
    FEBS J; 2011 Dec; 278(23):4506-15. PubMed ID: 21624052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze-fracture technique.
    Pumplin DW; Reese TS
    J Physiol; 1977 Dec; 273(2):443-57. PubMed ID: 202700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
    Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.
    Koriazova LK; Montal M
    Nat Struct Biol; 2003 Jan; 10(1):13-8. PubMed ID: 12459720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain.
    Pirazzini M; Henke T; Rossetto O; Mahrhold S; Krez N; Rummel A; Montecucco C; Binz T
    FEBS Lett; 2013 Nov; 587(23):3831-6. PubMed ID: 24157364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.
    Scott VL; Villarreal DO; Hutnick NA; Walters JN; Ragwan E; Bdeir K; Yan J; Sardesai NY; Finnefrock AC; Casimiro DR; Weiner DB
    Hum Vaccin Immunother; 2015; 11(8):1961-71. PubMed ID: 26158319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium-dependent release of norepinephrine from permeabilized PC12 cells is inhibited by approximately 48 and approximately 112 kDa fragments of botulinum neurotoxin type E.
    Lomneth R; Gimenez J; Martin TF; DasGupta BR
    Neuropharmacology; 1993 Mar; 32(3):285-9. PubMed ID: 8474625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ion-conducting channels produced by botulinum toxin in planar lipid membranes.
    Donovan JJ; Middlebrook JL
    Biochemistry; 1986 May; 25(10):2872-6. PubMed ID: 2424493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.
    Ambrin G; Kumar R; Singh BR
    Toxicon; 2018 Mar; 144():34-41. PubMed ID: 29309744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R; Rummel A; Binz T; Brunger AT
    Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of the functional activity of botulinum neurotoxin subtype B6.
    Kohda T; Nakamura K; Hosomi K; Torii Y; Kozaki S; Mukamoto M
    Microbiol Immunol; 2017 Nov; 61(11):482-489. PubMed ID: 28898517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Comprehensive Structural Analysis of
    Gregory KS; Acharya KR
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Features of
    Gregory KS; Mahadeva TB; Liu SM; Acharya KR
    Toxins (Basel); 2022 May; 14(5):. PubMed ID: 35622602
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.